Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Real-Time Live Tissue Sensitivity Assay for Pancreatic Adenocarcinoma

News

September 19, 2023
PRESS RELEASE: On September 15, 2023, a new research paper was published in Oncotarget, entitled, “Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma.” continue reading »

Systemic Treatment for Brain Metastasis in HER2-Positive Advanced Breast Cancer

News

September 13, 2023
PRESS RELEASE: On July 7, 2023, a new editorial was published in Oncotarget, entitled, “Systemic treatment for brain metastasis in HER2- positive advanced breast cancer: what have we learned so far?” continue reading »

Updates: MET Targeted Therapy for EXON 14 Mutations in Lung Cancer

News

September 11, 2023
PRESS RELEASE: On May 26, 2023, a new editorial was published in Oncotarget, entitled, “Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer.” continue reading »

Predicting Functions of Cancer-Associated Genetic Variants

Oncotarget

September 7, 2023
In a new editorial, researchers from the University of Illinois at Urbana-Champaign discuss the value of using computational models to predict the functions of cancer-associated genetic variants. continue reading »

Subpopulations of AIB1-Expressing Breast Cancer Cells Enable Invasion and Metastasis

News

September 6, 2023
PRESS RELEASE: On August 30, 2023, a new editorial was published in Oncotarget, entitled, “Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis.” continue reading »